Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Edwards Lifesciences Corp (NYSE:EW)

89.30
Delayed Data
As of 4:02pm ET
 +5.57 / +6.65%
Today’s Change
72.20
Today|||52-Week Range
121.75
+13.07%
Year-to-Date
5 Stocks With Big Insider Buying
Dec 07 / TheStreet.com - Paid Partner Content
MedTech Sails Through Macro Woes: Stocks in Focus
Dec 02 / Zacks.com - Paid Partner Content
'Mad Money Lightning Round: Go Long on Pandora
Dec 06 / TheStreet.com - Paid Partner Content
Edward Lifesciences (EW) to Buy Israel's Valtech Cardio
Nov 29 / Zacks.com - Paid Partner Content
Weekly Top Insider Buys Highlight for the Week of Dec. 2
Dec 04 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close83.73
Today’s open85.55
Day’s range85.27 - 91.34
Volume6,109,007
Average volume (3 months)1,845,984
Market cap$17.9B
Dividend yield--
Data as of 4:02pm ET, 12/08/2016

Growth & Valuation

Earnings growth (last year)-39.84%
Earnings growth (this year)+25.56%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+7.35%
P/E ratio35.3
Price/Sales6.98
Price/Book7.21

Competitors

 Today’s
change
Today’s
% change
SNNSmith & Nephew PLC+0.40+1.39%
ISRGIntuitive Surgical+0.45+0.07%
STESTERIS plc+0.45+0.67%
HRCHill-Rom Holdings In...+0.86+1.56%
Data as of 4:02pm ET, 12/08/2016

Financials

Next reporting dateFebruary 7, 2017
EPS forecast (this quarter)$0.73
Annual revenue (last year)$2.5B
Annual profit (last year)$494.9M
Net profit margin19.85%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Michael A. Mussallem
Chief Financial Officer &
Vice President
Scott B. Ullem
Corporate headquarters
Irvine, California

Forecasts


Search for Jobs